# BG & TMZ Therapy of Glioblastoma Multiforme

> **NCT01269424** · PHASE1 · COMPLETED · sponsor: **Stanton Gerson MD** · enrollment: 10 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **BIOLOGICAL:** MGMTP140K-encoding retroviral vector
- **DRUG:** O6-benzylguanine
- **DRUG:** temozolomide
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** autologous hematopoietic stem cell transplantation
- **PROCEDURE:** in vitro-treated peripheral blood stem cell transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT01269424
- **Lead sponsor:** Stanton Gerson MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-22
- **Primary completion:** 2020-12-07
- **Final completion:** 2022-09-26
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269424, "BG & TMZ Therapy of Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01269424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*